4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-057704
Director sold 3,665 shares at $17.78 ($65,164)
- Director acquired 10,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Curet Myriam · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-22 | Grant or award : show line 1 in the form | +10,200 | 29,440 | D | ||
| 2021-09-22 | Sale : show line 2 in the form | −3,665 | $17.78 | $65,164 | 25,775 | D |
| Open-market sales · 3,665 sh · avg $17.78 · $65,164 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-22 | Grant or award : show line 3 in the form Stock Option | +20,400 | 20,400 | D |
Loading xslF345X03/doc4.xml…